CAMX:STO
Camurus AB
SEKÂ 738.50
arrow_downward
-0.20%(-1.50) 1D
Nov 17, 9:49:36 AM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
SEKÂ 736.00
High
SEKÂ 739.00
Low
SEKÂ 734.50
Mkt. cap
45.12B
Avg. vol.
107.44K
Volume
17.94K
52-wk high
SEKÂ 750.00
52-wk low
SEKÂ 430.80
Shares outstanding
60.56M
No. of employees
323
Open
SEKÂ 736.00
High
SEKÂ 739.00
Low
SEKÂ 734.50
Mkt. cap
45.12B
Avg. vol.
107.44K
Volume
17.94K
52-wk high
SEKÂ 750.00
52-wk low
SEKÂ 430.80
Shares outstanding
60.56M
No. of employees
323
News stories
From web sources and news partners
Seeking Alpha
·
46 minutes ago
RDVI: The Dividend ETF Beating The S&P 500, And Almost Nobody Knows How (Rating Upgrade)
Reuters
·
9 hours ago
Wall Street ends sharply lower on AI jitters ahead of Nvidia results, Anthropic IPO
Yahoo Finance
·
2 hours ago
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees323
Founded1991
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecamurus.com